Efficacy subgroup analyses from the phase 3 CHAMPION-NMOSD trial in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

被引：0

作者：

Levy, Michael ^{[1
,2
]}

Pittock, Sean ^{[3
]}

Barnett, Michael ^{[4
]}

Bennett, Jeffrey ^{[5
,6
]}

Berthele, Achim ^{[7
]}

De Seze, Jerome ^{[8
,9
]}

Nakashima, Ichiro ^{[10
,11
]}

Guevara, Celia Oreja ^{[12
,13
]}

Palace, Jacqueline ^{[14
]}

Paul, Friedemann ^{[15
,16
,17
]}

Pozzilli, Carlo ^{[18
]}

Allen, Kerstin ^{[19
]}

Mashhoon, Yasmin ^{[19
]}

Yountz, Marcus ^{[19
]}

Kim, Ho Jin ^{[20
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA USA

[2] Harvard Med Sch, Boston, MA USA

[3] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia

[4] Royal Prince Alfred Hosp, Dept Neurol, Sydney, NSW, Australia

[5] Univ Colorado, Programs Neurosci & Immunol, Dept Neurol, Aurora, CO USA

[6] Univ Colorado, Programs Neurosci & Immunol, Dept Ophthalmol, Aurora, CO USA

[7] Tech Univ Munich, Sch Med, Dept Neurol, Munich, Germany

[8] CHU Strasbourg, Dept Neurol, Strasbourg, France

[9] CHU Strasbourg, Clin Invest Ctr, Strasbourg, France

[10] Tohoku Univ Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan

[11] Tohoku Med & Pharmaceut Univ, Div Neurol, Sendai, Miyagi, Japan

[12] IdISCC, Hosp Clinico Univ San Carlos, Dept Neurol, Madrid, Spain

[13] Univ Complutense Madrid, Dept Med, Madrid, Spain

[14] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford, England

[15] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany

[16] Max Delbruck Ctr Mol Med, Neurocure Clin Res Ctr, Berlin, Germany

[17] Charite Univ Med Berlin, Berlin, Germany

[18] Univ Sapienza, Dept Human Neurosci, Rome, Italy

[19] Alexion, AstraZeneca Rare Dis, Boston, MA USA

[20] Natl Canc Ctr, Dept Neurol, Goyang, South Korea

来源：

NEUROLOGY | 2023年 / 100卷 / 17期

关键词：

D O I：

10.1212/WNL.0000000000203035

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S5.003

引用

页数：8

共 50 条

[41] Alterations in the Brain Structure and Functional Connectivity in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder
Yan, Jueyue
Wang, Yu
Miao, Hanpei
Kwapong, William Robert
Lu, Yi
Ma, Qingkai
Chen, Wei
Tu, Yunhai
Liu, Xiaozheng
FRONTIERS IN NEUROSCIENCE, 2020, 13
[42] A Natural History Study of the Effect of Pregnancy on Aquaporin 4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.
Hor, Jyh Yung
Chow, Han Bing
Lim, Thien Thien
Chia, Yuen Kang
Tan, Kenny
Cheah, Chun Fai
Ching, Yee Ming
Arip, Masita
Easaw, P. E. Samuel
Eow, Gaik Bee
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 425 - 425
[43] Anti-aquaporin-4 Antibody Positive Relapsing Neuromyelitis Optica in a Patient With Systemic Lupus Erythematosus
Yildiz, Ozlem Kayim
Balaban, Hatice
Senel, Soner
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2011, 28 (03): : 376 - 379
[44] Impact of eculizumab on disability measures in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: phase 3 PREVENT study
Palace, J.
Pittock, S. J.
Berthele, A.
Fujihara, K.
Kim, H. J.
Levy, M.
Nakashima, I.
Terzi, M.
Totolyan, N.
Viswanathan, S.
Wang, K. -C.
Pace, A.
Yountz, M.
Armstrong, R.
Wingerchuk, D. M.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 737 - 738
[45] Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level
Nishimura, Hiroaki
Enokida, Hideki
Sakamoto, Taiji
Takahashi, Toshiyuki
Hayami, Hiroshi
Nakagawa, Masayuki
JOURNAL OF ARTIFICIAL ORGANS, 2018, 21 (03) : 378 - 382
[46] Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder.
Kessler, R. A.
Mealy, M. A.
Jimenez-Arango, J. A.
Quan, C.
Paul, F.
Levy, M.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 844 - 845
[47] Anti-Aquaporin-4 Antibody Production from Peripheral B Cells in Neuromyelitis Optica
Suzuki, Chihiro
Nakashima, Ichiro
Takahashi, Toshiyuki
Bar-Or, Amit
Itoyama, Yasuto
Fujihara, Kazuo
NEUROLOGY, 2009, 72 (11) : A281 - A282
[48] Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level
Hiroaki Nishimura
Hideki Enokida
Taiji Sakamoto
Toshiyuki Takahashi
Hiroshi Hayami
Masayuki Nakagawa
Journal of Artificial Organs, 2018, 21 : 378 - 382
[49] Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study
Fujihara, Kazuo
Berthele, Achim
Kim, Ho Jin
Levy, Michael
Nakashima, Ichiro
Oreja-Guevara, Celia
Palace, Jacqueline
Pittock, Sean J.
Terzi, Murat
Totolyan, Natalia
Viswanathan, Shanthi
Wang, Kai-Chen
Pace, Amy
Yountz, Marcus
Miller, Larisa
Tanvir, Imran
Armstrong, Roisin
Wingerchuk, Dean M.
NEUROLOGY, 2020, 94 (15)
[50] Aquaporin 4 positive Neuromyelitis Optica Spectrum Disorder in pediatric and adults patients from Chile
Castillo, Paula
De la Barra, Juan
Leon, Bernardita Soler
Pelayo, Carolina
Garcia, Lorena
Del Canto, Adolfo
Vera, Francisco
Carcamo, Claudia
Ciampi, Ethel
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 146 - 146

← 1 2 3 4 5 →